Redica Systems
  • Login
  • Request a Demo
  • Products
    • Regulatory Intelligence
    • Inspection Intelligence
    • Site Intelligence
  • Solutions
    • Redica Systems Pharma Intelligence
    • Redica Systems MedTech Intelligence
  • Data & Services
    • Redica App
    • Catalyst
  • Company
    • About Us
    • People
    • Careers
    • Press
  • Resources
    • Blog
    • Assessments
    • Reports
    • Webinars
    • Glossary
Redica Systems
    • Regulatory Intelligence
    • Inspection Intelligence
    • Site Intelligence
    • Redica Systems Pharma Intelligence
    • Redica Systems MedTech Intelligence
    • Redica App
    • Catalyst
    • About Us
    • People
    • Careers
    • Press
    • Blog
    • Assessments
    • Reports
    • Webinars
    • Glossary
  • Login
  • Request a Demo

Resources

FDA Sent These 8 Warning Letters for Pharma Companies | September 2016

We took a snapshot of the 8 warning letters the FDA sent to pharmaceutical companies last month. Drug manufacturing violations ranged from a product containing “hair and a black spider” to management failing to “document laboratory controls.” From pharmaceuticals in Japan, Brazil, and more, here they are (starting with the most recent): Delarange Cosmetics & […]

October: FDA cGMP Quality News Briefing

What industry news have you been reading this month? At FDAzilla, we’ve compiled the most noteworthy articles we’ve come across in the weeks since our last update. This month’s picks include information from two conferences, surprising warning letters abroad and in the US, an explanation QSIT protocol, and stories of both exemplary and reprehensible strategies from companies dealing with in-house deficiencies. Take […]

Last 30 483s Customers Have Purchased – September 2016

We see a lot of people, all throughout the world, purchasing 483s from our FDA 483s store. For example, this month, customers from the United States, Germany, Albania, India, and China purchased 483s.  As a reminder, here are 5 features to look for in a 483. Here are the latest 30 483s purchased from us: 1. […]

What do we do exactly? Give us 78 seconds.

Glad you asked! Learn more about how FDAzilla can help you achieve your quality and inspection preparation goals: get 483s, Inspector Profiles, Enforcement Analytics, and GMP Regulatory Intelligence. Contact me if you ever have questions at tony@fdazilla.com.

FDA Sent These 13 Warning Letters for Pharma Companies | August 2016

We took a snapshot of the 13 warning letters the FDA sent to pharmaceutical companies last month. Drug manufacturing violations ranged from failing to “maintain written records” to failing to wear “clothing appropriate to protect drug product.” From pharmaceuticals in Brazil, India, China, and 6 US states, here they are (starting with the most recent): […]

FDA cGMP Quality News Briefing: August-September

We’ve compiled August and September’s mostrelevant, important news foranyone concerned with Pharmaceutical Industry GMP and FDA inspections. Our top 12 picks are listed chronologically by publication date.Happy reading! July 25: After scandal, China begins vaccine inspections nationwide. — Discovery of a blackmarket vaccine ring earlier this year was the impetus for China’s nationwide campaign to inspect vaccine […]

17 New Featured FDA 483s | September 27, 2016

Here are the featured FDA 483s for the week. You can obtain these at the FDAzilla 483s store here>> Inspection End Date Company City/Local State/Region Country 1/22/2016 Amgen Manufacturing Limited Juncos PR United States 2/23/2015 Carlos Pantojas San Juan PR United States 9/25/2015 Charles River Laboratories Preclinical Services Reno NV United States 11/2/2015 Comprehensive Telemedicine […]

3 Key Learnings from the PDA/FDA Joint Conference

OVERALL:This is the 25th anniversary of the PDA/FDA conference and many of the presentations provided evidence of the significant progress made in research and medicine during this time.It was fascinating to stand back for a few moments to see just how far we’ve come.The overall conclusion I take from the two days of the conference […]

22 New Featured FDA 483s | September 20, 2016

Here are the featured FDA 483s for the week. You can obtain these at the FDAzilla 483s store here>> Inspection End Date Company City/Local State/Region Country 3/17/2014 Antonio Capone Royal Oak MI United States 10/14/2015 Applied BioPhotonics Ltd. Chupei City, Hsinchu District Taiwan (Province of China) 12/10/2015 Biogen US Corporation Research Triangle Park NC United […]

22 New Featured FDA 483s | September 13, 2016

Here are the featured FDA 483s for the week. You can obtain these at the FDAzilla 483s store here>> Inspection End Date Company City/Local State/Region Country 12/2/2015 Adapta Medical, Inc. Colorado Springs CO United States 9/18/2015 Apnea Sciences Corporation Aliso Viejo CA United States 11/9/2015 Ascent Pharmaceuticals, Inc. Central Islip NY United States 12/14/2015 Austin […]
« Older Entries
Newer Entries »
Company
  • About Redica Systems
  • People
  • Careers
  • Press
  • Contact Us
Catalyst
  • Redica Catalyst
  • Redica ID
  • Enrichment
  • Knowledge Graph
  • Redica Ontologies
Use Cases
  • For Pharma
  • For MedTech
  • Inspection Preparation
  • Vendor Quality
  • Regulatory Surveillance
Resources
  • Assessments
  • Reports
  • Webinars
  • Document Store
  • Blog
  • Glossary

© 2025 Redica. All Rights Reserved.

  • Privacy Policy
  • Terms of Use
  • Status